Search | IOVS | ARVO Journals

View

Showing 1 – 12 of 12

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2013

Semi-automated Contour Analysis of SD-OCT images after Epiretinal Membrane Peeling using either air tamponade or balanced salt solution

Focke Ziemssen; Martin Leitritz; Ditta Zobor; Michael Voelker; Karl-Ulrich Bartz-Schmidt; Faik Gelisken

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):5506. doi:

ARVO Annual Meeting Abstract March 2012

Focal Choroidal Edema (FCE) - Activity Sign Of Or Prior To Chorodial Neovascularizations Secondary To Pathologic Myopia?

Focke Ziemssen; Werner Inhoffen; Michael Voelker; Karl Ulrich Bartz-Schmidt

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):4439. doi:

ARVO Annual Meeting Abstract April 2010

Intravitreal Bevacizumab Monotherapy for Retinal Angiomatous Proliferation: One- and Two Year Results

F. Gelisken; M. Voelker; W. Inhoffen; K. U. Bartz-Schmidt; F. Ziemssen

Invest. Ophthalmol. Vis. Sci.. 2010; 51(13):904. doi:

ARVO Annual Meeting Abstract April 2009

Intravitreal Bevacizumab for Choroidal Neovascularisation in Pathological Myopia: 2-Years Results

B. Voykov; F. Ziemssen; M. Voelker; W. Inhoffen; K. Bartz-Schmidt; F. Gelisken

Invest. Ophthalmol. Vis. Sci.. 2009; 50(13):2281. doi:

ARVO Annual Meeting Abstract April 2009

Long-Term Follow-Up of Intravitreal Bevacizumab in Serous Retinal Pigment Epithelial Detachment

F. Ziemssen; F. Gelisken; M. Voelker; W. Inhoffen; S. Grisanti; K. U. Bartz-Schmidt

Invest. Ophthalmol. Vis. Sci.. 2009; 50(13):5002. doi:

ARVO Annual Meeting Abstract May 2008

Intravitreal Bevacizumab for Neovascular Age-Related Macular Degeneration: 12 Months Results

B. Voykov; F. Ziemssen; M. Voelker; W. Inhoffen; K. U. Bartz-Schmidt; F. Gelisken

Invest. Ophthalmol. Vis. Sci.. 2008; 49(13):275. doi:

ARVO Annual Meeting Abstract May 2006

Assessment of the Morphological Outcome of the Macula After Full Macular Translocation by Optical Coherence Tomography : One Year Follow–Up Results

A. Bilgic; F. Gelisken; C. Kucukerdonmez; M. Voelker; K.U. Bartz–Schmidt

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):2157. doi:

ARVO Annual Meeting Abstract May 2006

Confocal Scanning Laser Tomography of the Disc after Intravitreous Triamcinolone Acetonide (Volon A)

M.A. Leitritz; W. Inhoffen; M. Voelker; F. Ziemssen; K.–U. Bartz–Schmidt

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):4267. doi:

ARVO Annual Meeting Abstract May 2006

Analysis of Functional and Morphological Outcomes of Full Macular Translocation Prior and Following to Photodynamic Therapy in Neovascular Age–Related Macular Degeneration

D. Suesskind; F. Gelisken; M. Voelker; W. Inhoffen; M. Partsch; S. Grisanti; K. Bartz–Schmidt

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):354. doi:

ARVO Annual Meeting Abstract May 2005

Impact and Consequences of Verteporfin Photodynamic Therapy on Choroidal Neovascular Membranes

O. Tatar; A. Adam; B. Lafaut; M. Voelker; F. Gelisken; K. Shinoda; K. Bartz–Schmidt; S. Grisanti

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):5302. doi:

ARVO Annual Meeting Abstract May 2004

Retinal neurodegeneration in the DBA/2J mouse – a model for ocular hypertension

S. Thaler; F. Schuettauf; R. Rejdak; M. Walski; M. Frontczak–Baniewicz; M. Voelker; K. Shinoda; Z. Zagorski; E. Zrenner; P. Grieb

Invest. Ophthalmol. Vis. Sci.. 2004; 45(13):892. doi:

ARVO Annual Meeting Abstract December 2002

Histopathologic Findings of Surgically Excised Choroidal Neovascularization Three Days Following Photodynamic Therapy in Age-related Macular Degeneration

F Gelisken; B Lafaut; W Inhoffen; M Voelker; S Grisanti; KU Bartz-Schmidt

Invest. Ophthalmol. Vis. Sci.. 2002; 43(13):587. doi:

Advertisement